In addition, as a group of immunosuppressive lymphocytes, Foxp3+TILs alone did not show any prognostic effects in patients with stage I NSCLC, but patients with low-Foxp3/high-CD8+TILs tended to have prolonged DFS. This evidence concerns the gene FOXP3 and non-small cell lung carcinoma.